
NeoGenomics NEO
$ 8.22
2.75%
Annual report 2025
added 02-17-2026
NeoGenomics Current Ratio 2011-2026 | NEO
Annual Current Ratio NeoGenomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.6 | 2.23 | 2.27 | 2.35 | 2.46 | 3.36 | 4.55 | 1.7 | 2.42 | 2.07 | 2.47 | 4.02 | 1.92 | 1.05 | 1.15 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.55 | 1.05 | 2.44 |
Quarterly Current Ratio NeoGenomics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.58 | 2.25 | 2.23 | 2.24 | 2.26 | 2.29 | 2.27 | 2.3 | 2.29 | 2.33 | 2.35 | 2.36 | 2.39 | 2.42 | 2.46 | 2.48 | 2.54 | 2.3 | 3.36 | 3.36 | 3.36 | 3.36 | 3.51 | 3.51 | 3.51 | 3.51 | 2.74 | 2.74 | 2.74 | 2.74 | 2.46 | 2.46 | 2.46 | 2.46 | 2.24 | 2.24 | 2.24 | 2.24 | 3.1 | 3.1 | 3.1 | 3.1 | 3.92 | 3.92 | 3.92 | 3.92 | 2.19 | 2.19 | 2.19 | 2.19 | 1.44 | 1.44 | 1.44 | 1.44 | 1.42 | 1.42 | 1.42 | 1.42 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.92 | 1.42 | 2.55 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
5.26 | $ 19.25 | 7.36 % | $ 205 M | ||
|
Agilent Technologies
A
|
2.01 | $ 121.16 | 3.11 % | $ 36.8 B | ||
|
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
3.75 | $ 17.41 | 3.45 % | $ 928 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
6.01 | $ 1.43 | -1.37 % | $ 1.9 M | ||
|
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
7.05 | $ 24.69 | 4.93 % | $ 686 M | ||
|
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
1.82 | $ 180.3 | 1.1 % | $ 8.94 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | ||
|
Interpace Biosciences
IDXG
|
2.95 | $ 2.2 | - | $ 9.73 M | ||
|
Danaher Corporation
DHR
|
5.19 | $ 198.81 | 1.5 % | $ 142 B | ||
|
Medpace Holdings
MEDP
|
1.3 | $ 517.09 | 3.16 % | $ 14.9 B | ||
|
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
6.69 | $ 130.78 | 3.01 % | $ 20.8 B | ||
|
Myriad Genetics
MYGN
|
2.09 | $ 4.79 | 4.25 % | $ 444 M | ||
|
Fulgent Genetics
FLGT
|
13.4 | $ 15.8 | 3.27 % | $ 478 M | ||
|
Natera
NTRA
|
2.02 | $ 211.29 | 4.65 % | $ 20.8 B | ||
|
Guardant Health
GH
|
0.953 | $ 85.71 | 4.26 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
7.55 | $ 2.83 | -0.7 % | $ 91.8 K | ||
|
Biomerica
BMRA
|
3.23 | $ 2.04 | -1.92 % | $ 4.69 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.69 | $ 29.1 | 1.91 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
2.29 | $ 112.9 | 2.29 % | $ 9.31 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 266.64 | 0.93 % | $ 22.2 B | ||
|
Celcuity
CELC
|
1.27 | $ 120.26 | -0.12 % | $ 5.62 B | ||
|
Neogen Corporation
NEOG
|
2.51 | $ 9.49 | 3.88 % | $ 2.06 B | ||
|
Lantheus Holdings
LNTH
|
1.96 | $ 82.98 | 1.6 % | $ 5.6 B | ||
|
Senseonics Holdings
SENS
|
1.94 | $ 6.79 | 0.97 % | $ 283 M | ||
|
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | ||
|
Soleno Therapeutics
SLNO
|
4.96 | $ 52.64 | -0.01 % | $ 2.68 B | ||
|
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 193.31 | 0.23 % | $ 21.5 B | ||
|
ENDRA Life Sciences
NDRA
|
2.42 | $ 4.94 | -4.74 % | $ 3.89 M | ||
|
Neuronetics
STIM
|
1.23 | $ 1.42 | 2.16 % | $ 93.7 M | ||
|
National Research Corporation
NRC
|
1.12 | $ 17.1 | 1.69 % | $ 383 M |